首页> 外国专利> Screening for compounds having immunosuppressant activity by testing impact on leukocyte-specific calcium fluxes

Screening for compounds having immunosuppressant activity by testing impact on leukocyte-specific calcium fluxes

机译:通过测试对白细胞特异性钙通量的影响来筛选具有免疫抑制活性的化合物

摘要

The invention relates to an assay for the identification of a compound having immunosuppressant activity, wherein a candidate compound is analyzed whether it blocks the Ca2+ flux in coronin 1 expressing cells and/or in coronin 1 negative cells. A candidate compound is identified as having immunosuppressant activity if it blocks the Ca2+ flux specifically in coronin 1 expressing cells. Further described are upstream assays wherein the impact of a candidate compound on coronin 1 trimerization is measured, and downstream assays wherein the impact of a candidate compound on diacyl glycerol (DAG) generation, phosphatidylinositol-4,5-biphosphate (PIP2) levels and/or inositol-1,4,5-triphosphate (InsP3) generation or on nuclear factor of activated T cells (NFAT) nuclear localization is determined.
机译:本发明涉及一种鉴定具有免疫抑制活性的化合物的测定法,其中分析了候选化合物是否阻断了表达Coronin 1的细胞和/或Coronin 1阴性细胞中的Ca 2 + 通量。 。如果候选化合物特异性地阻断表达Coronin 1的细胞中的Ca 2 + 通量,则该化合物被鉴定为具有免疫抑制活性。还描述了上游测定,其中测定了候选化合物对冠蛋白1三聚化的影响,下游测定中,候选化合物对二酰基甘油(DAG)生成,磷脂酰肌醇-4,5-双磷酸酯(PIP 2 )水平和/或肌醇-1,4,5-三磷酸(InsP 3 )的生成或激活T细胞的核因子(NFAT)的核定位。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号